This warehouse cannot ship to Military addresses, Norway, Denmark, Israel, Alaska, Hawaii, Puerto Rico and Guam.
DO NOT order if you are based in these locations.
Respectfully,
OSGear Team
Powerful Women Cycle - Ultima Pharmaceuticals - Cycles
5 x Ultima-Primo 100 - Ultima Pharmaceuticals [10 ml x 100 mg/ml]
7 x Ultima-Win - Ultima Pharmaceuticals [10 ml x 50 mg/ml]
1 x Ultima-Clomid - Ultima Pharmaceuticals [50 pills x 50 mg]
2 x Ultima-Salbuto - Ultima Pharmaceuticals [50 pills x 2 mg]
MANUFACTURER Ultima Pharmaceuticals - Cycles
WAREHOUSE International Warehouse 3
SUBSTANCE
Clomiphene Citrate,
Methenolone Enanthate,
Stanozolol Suspension,
Salbutamol,
Powerful Women Cycle
Brand: Ultima Pharmaceuticals
9 WEEKS POWERFUL WOMEN CYCLE BY ULTIMA PHARMACEUTICALS
Insane cutting, removing of excess liquid with distinct vascularity and powerful pumping. Despite a “weak” Primobolan it’s a pretty powerful combination, working precisely on muscle definition. Beachgoers respect the stack for his efficiency and expressed fat-burn thanks to Winstrol included in its composition. Is a popular kind of summer prep cycles. Supersets and highly intensive workouts – best training programs for this stack.
Winny removes excess fluid (including the articular capsule) but quickly develops the strength. That can be traumatic, because of the dryness of the ligaments. A small working weights, intense superset work-out – the best way to get maximum out of this combination without injury. For the eight-week cycle on this combo is easy to get 5 kg of high quality muscle. PCT and proper diet is the key to saving up to 90% of result.
Ultima-Primo 100: 150 mg every other day
Ultima-Win: 50 mg / day
PCT: Ultima-Clomid and Ultima-Salbuto
We are not professionals and under no circumstances should our advice be taken as so or over the instructions of a professional, we are simply sharing experience.
Please be informed that OSGear do NOT assume any responsibility for the eventual issues during the cycle, wrong administration of the products or results.
